Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7759530 | 0.83 | ALDH1A1 (0.64) | ALDH1A1CYP1A2RAB9ASMN1; SMN2S1PR2 | |
| SCHEMBL639563 | 0.83 | ALDH1A1 (0.64) | ALDH1A1CYP1A2RAB9ASMN1; SMN2S1PR2 | |
| SCHEMBL19555119 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP1A2RAB9AS1PR2S1PR4 | |
| Hydrochloric Acid SCHEMBL4200885 | 0.82 | ALDH1A1 (0.62) | ALDH1A1CYP1A2RAB9ASMN1; SMN2S1PR2 | |
| Hydrochloric Acid SCHEMBL27529639 | 0.82 | ALDH1A1 (0.62) | ALDH1A1CYP1A2RAB9ASMN1; SMN2S1PR2 | |
| SCHEMBL6436240 | 0.80 | CYP1A2 (0.43) | ALDH1A1CYP1A2GRM4S1PR3SLC6A2 | |
| SCHEMBL29893620 | 0.79 | AURKA (0.40) | — | |
| SCHEMBL28889316 | 0.79 | AURKA (0.40) | — | |
| SCHEMBL23366716 | 0.77 | SLC6A2 (0.46) | GRM4HDAC6NFKB1S1PR2S1PR4 | |
| SCHEMBL132880 | 0.77 | SLC6A2 (0.46) | ALDH1A1CYP1A2GRM4HDAC6S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9463187-B2 | Methylphenidate derivatives and uses of them | AMPIO PHARMACEUTICALS, INC. (US) | 2016-10-11 | — | — | US | disclosed |
| US-20120101129-A1 | Methylphenidate Derivatives and Uses of Them | AMPIO PHARMACEUTICALS, INC. | 2012-04-26 | — | — | US | disclosed |
| US-8076485-B2 | Methylphenidate derivatives and uses of them | INSTITUTE FOR MOLECULAR MEDICINE, INC. (US) | 2011-12-13 | — | — | US | disclosed |
| US-7459467-B2 | Manufacturing process for methyl phenidate and intermediates thereof | IPCA LABORATORIES, LTD. (IN) | 2008-12-02 | — | — | US | disclosed |
| EP-1607388-B1 | An improved manufacturing process for methylphenidate and intermediates thereof | IPCA LAB LTD (IN) | 2008-02-20 | — | — | EP | disclosed |
| EP-1607388-A1 | An improved manufacturing process for methylphenidate and intermediates thereof | IPCA Laboratories Limited (IN) | 2005-12-21 | — | — | EP | disclosed |
| US-20050277667-A1 | Manufacturing process for methyl phenidate and intermediates thereof | IPCA LABORATORIES LIMITED (IN) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277667-A1 | Manufacturing process for methyl phenidate and intermediates thereof | COMT, ADH1C, CYP4B1 | ALDH1A1 109/4885CYP1A2 20/4885GRM4 256/4885 |
| US-20120101129-A1 | Methylphenidate Derivatives and Uses of Them | SLC6A3, COMT, UGT1A1 | ALDH1A1 335/4885CYP1A2 22/4885GRM4 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.